GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach

被引：0
|
作者：
Isabella Crisci
Michele Aragona
Konstantina Savvina Politi
Giuseppe Daniele
Stefano Del Prato
机构：
[1] University of Pisa,Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes
来源：
Acta Diabetologica | 2015年 / 52卷
关键词：
Liraglutide; Type 1 diabetes; Insulin pump therapy; Continuous glucose monitoring; Glycemic variability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1129 / 1133
页数：4
相关论文
共 50 条
  • [41] Defining the role of GLP-1 receptor agonists for individualized treatment of Type 2 diabetes
    Yabe, Daisuke
    Seino, Yutaka
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (06) : 659 - 670
  • [42] Should GLP-1 Receptor Agonists Be the First Line of Treatment for Type 2 Diabetes?
    Pratley, Richard E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (11) : 671 - 673
  • [43] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Bahtiyar, Gul
    Pujals-Kury, Jean
    Sacerdote, Alan
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [44] The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
    Aroda, Vanita R.
    Ratner, Robert
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (06) : 528 - 542
  • [45] SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
    Davila, Esteban
    Mccormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (04) : 408 - 411
  • [46] The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes
    Thomas, Merlin C.
    DIABETES & METABOLISM, 2017, 43 : 2S20 - 2S27
  • [47] Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
    Chuang, Min-Hsiang
    Chen, Jui-Yi
    Wang, Hsien-Yi
    Jiang, Zheng-Hong
    Wu, Vin-Cent
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [48] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Gül Bahtiyar
    Jean Pujals-Kury
    Alan Sacerdote
    Current Diabetes Reports, 2018, 18
  • [49] Use of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Type 2 Diabetes
    Kukla, A.
    Hill, J.
    Merzkani, M.
    Bentall, A.
    Lorenz, E.
    Park, W.
    Shah, P.
    Issa, N.
    Stegall, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 955 - 955
  • [50] The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes
    Russell-Jones, D.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) : 1402 - 1414
12345